ATE205843T1 - Heterocyclische verbindungen zur behandlung von neurogener entzündung - Google Patents
Heterocyclische verbindungen zur behandlung von neurogener entzündungInfo
- Publication number
- ATE205843T1 ATE205843T1 AT96907328T AT96907328T ATE205843T1 AT E205843 T1 ATE205843 T1 AT E205843T1 AT 96907328 T AT96907328 T AT 96907328T AT 96907328 T AT96907328 T AT 96907328T AT E205843 T1 ATE205843 T1 AT E205843T1
- Authority
- AT
- Austria
- Prior art keywords
- heterocyclic compounds
- neurogenic inflammation
- treating neurogenic
- inflammation
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK40695 | 1995-04-07 | ||
DK100395 | 1995-09-11 | ||
PCT/DK1996/000140 WO1996031499A1 (en) | 1995-04-07 | 1996-04-01 | Novel heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE205843T1 true ATE205843T1 (de) | 2001-10-15 |
Family
ID=26063930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96907328T ATE205843T1 (de) | 1995-04-07 | 1996-04-01 | Heterocyclische verbindungen zur behandlung von neurogener entzündung |
Country Status (9)
Country | Link |
---|---|
US (2) | US5716949A (de) |
EP (1) | EP0869954B1 (de) |
JP (1) | JPH11503128A (de) |
AT (1) | ATE205843T1 (de) |
AU (1) | AU5100496A (de) |
CA (1) | CA2217130A1 (de) |
DE (1) | DE69615397D1 (de) |
IL (1) | IL117811A0 (de) |
WO (1) | WO1996031499A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001501629A (ja) * | 1996-10-04 | 2001-02-06 | ノボ ノルディスク アクティーゼルスカブ | N―置換アザ複素環式化合物 |
ZA978792B (en) * | 1996-10-04 | 1998-04-06 | Novo Nordisk As | N-substituted azaheterocyclic compounds. |
US7355042B2 (en) | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
US6934812B1 (en) * | 2001-10-22 | 2005-08-23 | Apple Computer, Inc. | Media player with instant play capability |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL256053A (de) * | 1959-09-22 | |||
US3391136A (en) * | 1963-09-13 | 1968-07-02 | Boehringer Sohn Ingelheim | 3-chloro-11-(upsilan-dimethylaminopropylidene)-5, 6-dihydromorphanthridine and derivatives |
US3381000A (en) * | 1963-10-16 | 1968-04-30 | Colgate Palmolive Co | Certain 11-basic substituted-5, 6-dihydromorphanthridine compounds |
US3542790A (en) * | 1966-12-07 | 1970-11-24 | Mead Johnson & Co | Substituted 5,11-dihydro-10,10-dioxodibenzo(c,f)(1,2)thiazepines |
US4181655A (en) * | 1973-08-24 | 1980-01-01 | Research Institute For Medicine And Chemistry Inc. | 5(3-Substituted aminopropyl)-10-trifluoromethoxy-5H-dibenz[b,f]azepines |
US3968217A (en) * | 1974-04-22 | 1976-07-06 | A. H. Robins Company, Incorporated | 5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz[b,f]azepines |
US3993757A (en) * | 1975-06-06 | 1976-11-23 | Richardson-Merrell Inc. | Method of treating inflammation with morphanthridines |
FR2594827B1 (fr) * | 1986-02-21 | 1988-05-20 | Adir | Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
IT1225729B (it) * | 1988-08-12 | 1990-11-26 | Menarini S A S Firenze A | Derivati della 5,5-diossido-6,11-diidrodibenzo (c,f)(1,2,5) tiadiazepina, loro sali e relativi procedimenti di fabbricazione |
MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
-
1996
- 1996-03-28 US US08/625,562 patent/US5716949A/en not_active Expired - Fee Related
- 1996-04-01 DE DE69615397T patent/DE69615397D1/de not_active Expired - Lifetime
- 1996-04-01 CA CA002217130A patent/CA2217130A1/en not_active Abandoned
- 1996-04-01 AT AT96907328T patent/ATE205843T1/de not_active IP Right Cessation
- 1996-04-01 WO PCT/DK1996/000140 patent/WO1996031499A1/en active IP Right Grant
- 1996-04-01 AU AU51004/96A patent/AU5100496A/en not_active Abandoned
- 1996-04-01 JP JP8529869A patent/JPH11503128A/ja active Pending
- 1996-04-01 EP EP96907328A patent/EP0869954B1/de not_active Expired - Lifetime
- 1996-04-03 IL IL11781196A patent/IL117811A0/xx unknown
-
1997
- 1997-05-22 US US08/862,169 patent/US5753643A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5753643A (en) | 1998-05-19 |
US5716949A (en) | 1998-02-10 |
WO1996031499A1 (en) | 1996-10-10 |
DE69615397D1 (de) | 2001-10-25 |
CA2217130A1 (en) | 1996-10-10 |
EP0869954B1 (de) | 2001-09-19 |
IL117811A0 (en) | 1996-08-04 |
AU5100496A (en) | 1996-10-23 |
EP0869954A1 (de) | 1998-10-14 |
JPH11503128A (ja) | 1999-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69516394T2 (de) | Neue heterocyclische verbindungen | |
MX9707531A (es) | Nuevos compuestos heterociclicos. | |
EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
ES2191069T3 (es) | Diaril-2-(5h)-furanonas como inhibidores de cox-2. | |
DE69735090D1 (de) | Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen | |
DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
ATE339205T1 (de) | (3-ä3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl pyrimidin-2-yl)-amino)-propoxyü-phenyl)- essigsäure und verwandte verbindungen als modulatoren von ppars und verfahren zur behandlung von stoffwechselstörungen | |
DE69615169D1 (de) | N-substituierte azaheterocyclische Carbonsäuren und ihre Alkylester | |
BR0109328A (pt) | Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica | |
ATE205843T1 (de) | Heterocyclische verbindungen zur behandlung von neurogener entzündung | |
ATE266027T1 (de) | Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten | |
ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
IL117812A0 (en) | N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them | |
DE60219680D1 (de) | Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit | |
DE602004016841D1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen | |
DE60108775D1 (de) | Methode zur behandlung von schlaganfall | |
ATE355834T1 (de) | Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |